Showing results (571-580 of 2,509) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|August 20, 2023
Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression OutcomesEfstathios Kastritis, Maria Gavriatopoulou, Eirini Solia, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 16, 2023
SOHO State of the Art Updates and Next Questions | Treatment of Richter's TransformationIlaria Romano, Adalgisa Condoluci, Davide Rossi
Clinical Lymphoma, Myeloma & Leukemia|January 11, 2024
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic LeukemiaNicholas J Short, Elias Jabbour, Trevor Jamison, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2024
SOHO State of the Art Updates and Next Questions | Next Questions: Acute Lymphoblastic LeukemiaJayastu Senapati, Hagop Kantarjian, Fadi G Haddad, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2024
Immunoglobulin High Throughput Sequencing (Ig-HTS) Minimal Residual Disease (MRD) Analysis is an Effective Surveillance Tool in Patients With Mantle Cell LymphomaAlexandra Rezazadeh, Julie Pruett, Amy Detzner, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2024
Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II TrialMatthew Matasar, Nancy L Bartlett, Mazyar Shadman, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 27, 2023
SOHO State of the Art Updates and Next Questions: Chronic Myeloid Leukemia and Pregnancy: "Per Aspera Ad Astra"Elisabetta Abruzzese, Malgorzata Monika Trawinska, Paolo De Fabritiis, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 7, 2024
SOHO State of the Art Updates and Next Questions: Update on the Approach to Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaFadi G Haddad, Elias Jabbour, Nicholas J Short, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2023
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple MyelomaSarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2023
SOHO State of the Art Update and Next Questions: Novel Therapies for Polycythemia VeraLucia Masarova, Helen T Chifotides
Pageof 251